Paper14737178
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
Steelman LS and 5 others. Leukemia, 2004. Cited by 578 papers, by iCite.
Cite this record
ConductScience Library. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Papers, record 14737178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14737178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| Leukemia | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Apoptosis | |
| Fusion Proteins, bcr-abl | |
| Humans | |
| Protein Kinases | |
| Receptors, Cytokine |
Source PubMed
References459
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3037531 | Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3037531 | PubMed |
| 2 | 10698713 | Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. | Biochem J | 2000 | https://conductscience.org/library/papers/10698713 | PubMed |
| 3 | 10558995 | Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. | Science | 1999 | https://conductscience.org/library/papers/10558995 | PubMed |
| 4 | 7697542 | Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. | Immunity | 1995 | https://conductscience.org/library/papers/7697542 | PubMed |
| 5 | 12529653 | Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. | Leukemia | 2003 | https://conductscience.org/library/papers/12529653 | PubMed |
| 6 | 12186863 | A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12186863 | PubMed |
| 7 | 8389691 | Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. | EMBO J | 1993 | https://conductscience.org/library/papers/8389691 | PubMed |
| 8 | 10822371 | The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. | Oncogene | 2000 | https://conductscience.org/library/papers/10822371 | PubMed |
| 9 | 12594806 | A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? | Int J Cancer | 2003 | https://conductscience.org/library/papers/12594806 | PubMed |
| 10 | 10704678 | Complex karyotype and N-RAS point mutation in a case of acute megakaryoblastic leukemia (M7) following a myelodysplastic syndrome. | Cancer Genet Cytogenet | 2000 | https://conductscience.org/library/papers/10704678 | PubMed |
| 11 | 10523635 | BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10523635 | PubMed |
| 12 | 9680354 | Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5. | Blood | 1998 | https://conductscience.org/library/papers/9680354 | PubMed |
| 13 | 7759531 | Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7759531 | PubMed |
| 14 | 11516100 | Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. | Leukemia | 2001 | https://conductscience.org/library/papers/11516100 | PubMed |
| 15 | 7651428 | RAS signalling is abnormal in a c-raf1 MEK1 double mutant. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7651428 | PubMed |
| 16 | 10888033 | PKC412--a protein kinase inhibitor with a broad therapeutic potential. | Anticancer Drug Des | 2000 | https://conductscience.org/library/papers/10888033 | PubMed |
| 17 | 12458225 | Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12458225 | PubMed |
| 18 | 7657393 | Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. | Int J Cancer | 1995 | https://conductscience.org/library/papers/7657393 | PubMed |
| 19 | 12476305 | Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571. | Oncogene | 2002 | https://conductscience.org/library/papers/12476305 | PubMed |
| 20 | 10196176 | Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10196176 | PubMed |
Cited by309
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 578 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857533 | Perioperative care of patients with chronic myeloid leukemia on tyrosine kinase inhibitors. | Front Oncol | 2026 | https://conductscience.org/library/papers/42857533 | PubMed |
| 42504206 | Deciphering the Multi-Target Therapeutic Mechanisms of Traditional Chinese Medicine Against Alzheimer's Disease: A Network Pharmacology Perspective. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42504206 | PubMed |
| 42065040 | Data Mining for Identification of Targets and Repurposed Drugs to Eliminate Persistent Chronic Myeloid Leukaemia Stem Cells: Targeting RAS/RAF Signalling. | Oncol Res | 2026 | https://conductscience.org/library/papers/42065040 | PubMed |
| 41977180 | A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977180 | PubMed |
| 41810235 | Current research on the HIF-2α-EPO-Hb axis in hypoxic environments: from molecular mechanisms to clinical. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41810235 | PubMed |
| 41428228 | Computational screening of natural phenolic compounds as potential EGFR inhibitors against triple negative breast cancer. | J Mol Model | 2025 | https://conductscience.org/library/papers/41428228 | PubMed |
| 41114875 | Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41114875 | PubMed |
| 40948582 | Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40948582 | PubMed |
| 40911615 | Gene expression profiling and pathway analysis in acute myeloid leukaemia-normal karyotype patients. | PLoS One | 2025 | https://conductscience.org/library/papers/40911615 | PubMed |
| 40075566 | Lycorine hydrochloride Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting TRIM22 and Inhibiting the JAK2/STAT3 and Erk Pathways. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075566 | PubMed |
| 39980929 | Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells. | Front Public Health | 2025 | https://conductscience.org/library/papers/39980929 | PubMed |
| 39739720 | Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. | PLoS One | 2024 | https://conductscience.org/library/papers/39739720 | PubMed |
| 39567540 | Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting. | Nat Commun | 2024 | https://conductscience.org/library/papers/39567540 | PubMed |
| 39510293 | Lessons learned from 20 years of preclinical testing in pediatric cancers. | Pharmacol Ther | 2024 | https://conductscience.org/library/papers/39510293 | PubMed |
| 39327314 | Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report. | Ann Hematol | 2024 | https://conductscience.org/library/papers/39327314 | PubMed |
| 39258309 | NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2. | J Cell Sci | 2024 | https://conductscience.org/library/papers/39258309 | PubMed |
| 39217250 | Reversible control of kinase signaling through chemical-induced dephosphorylation. | Commun Biol | 2024 | https://conductscience.org/library/papers/39217250 | PubMed |
| 39138146 | Therapeutic advances of targeting receptor tyrosine kinases in cancer. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39138146 | PubMed |
| 38947742 | Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | Genes Dis | 2024 | https://conductscience.org/library/papers/38947742 | PubMed |
| 38743735 | Identification of triciribine as a novel myeloid cell differentiation inducer. | PLoS One | 2024 | https://conductscience.org/library/papers/38743735 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| ZHX2 | 22882 | PubTator's text mining | https://conductscience.org/library/genes/22882 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14737178
GET https://conductscience.org/api/papers/v1/14737178/references?page=2